New hope for liver cancer patients: major trial tests powerful drug combo
Disease control
Recruiting now
This study is testing whether adding standard chemotherapy to two newer cancer drugs helps people with advanced liver cancer live longer. Researchers will compare two treatment approaches in 326 patients who haven't had previous systemic treatment. The main goals are to see which…
Phase: PHASE3 • Sponsor: Linhui Peng • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC